Caricamento...
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti‐vascular endothelial growth factor (anti‐VEGF) can reduce oedema, improve vision and prevent further visual loss. These drugs have replaced laser photocoagulation as the stand...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2018
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517135/ https://ncbi.nlm.nih.gov/pubmed/30325017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007419.pub6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|